Eton Pharmaceuticals, Inc. (ETON) Operating income 2018–2025
Eton Pharmaceuticals, Inc. (ETON) annual operating income history from SEC filings — each fiscal year as reported.
-$844,000FY2025 · since FY2018: -$10.3M → -$844,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$844,000 | +67.5% |
| FY2024 | -$2.6M | -117.9% |
| FY2023 | -$1.2M | +85.6% |
| FY2022 | -$8.3M | -452.5% |
| FY2021 | -$1.5M | +94.5% |
| FY2020 | -$27.1M | -45.8% |
| FY2019 | -$18.6M | -80.2% |
| FY2018 | -$10.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ETON financial trends
ETON RevenueETON Net incomeETON Net marginETON Gross profitETON Gross marginETON Operating marginETON Operating cash flowETON Free cash flowETON Capital expendituresETON Return on equityETON Stock buybacksETON Dividends paidETON Total assetsETON Total liabilitiesETON Shareholders’ equityETON overview →